RVMD Revolution Medicines, Inc.
$188.72▲ +1.34%
Healthcare
Other
Volume 889.4K
Avg Volume (10D) 1.96M
Key Metrics & Fundamentals
Market Cap
$40.45B
P/E Ratio
–
Div Yield
0.00%
52W Range
56.66 - 224.31
% vs 50 MA
-5.70%
% vs 200 MA
21.49%
RSI-14
46.3
MACD Histogram
-0.1200
Beta (1Y vs SPY)
1.15
Free Cash Flow
-$745.31M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$460.52M
COGS
–
Operating Exp
$505.13M
Operating Income
-$505.13M
EBIT
-$505.13M
Pretax Income
-$644.37M
Net Income
-$644.37M
EPS (Diluted)
-3.06
Price & Volume History
Loading chart…
Recent News
Billionaire Stanley Druckenmiller Added to Revolution Medicines Before Its FDA Win. Is the Stock Still a Buy After a 134% Run?
Motley Fool · Oct 27, 2026 6:01 PM ET
Revolution Medicines to Participate in November 2026 Investor Conferences
GlobeNewswire · Oct 27, 2026 4:05 PM ET
What 3 multibillion dollar biotechs still have to prove
Pharma Voice · Oct 27, 2026 8:48 AM ET
Cantargia Appoints Dr. Monic Stuart as Chief Medical Officer
ACCESS Newswire · Oct 26, 2026 4:45 AM ET
Roche Targets Emerging Oncology Market With New Lung-Cancer Drug
The Wall Street Journal · Oct 25, 2026 8:21 PM ET
ESMO26: Clinical progress shifts a historically difficult pancreatic cancer landscape
Clinical Trials Arena · Oct 25, 2026 6:38 AM ET
Revolution Medicines (RVMD) Stock Looks Above Fair Value Today
Simply Wall St. · Oct 24, 2026 7:15 PM ET
Revolution Medicines (RVMD) Following New Pancreatic Cancer Data Looks Undervalued
Simply Wall St. · Oct 24, 2026 1:11 PM ET
Moderna’s Cancer-Vaccine Leak Spurs Panic Selling. Wall Street Wanted a Cure.
Barrons.com · Oct 23, 2026 4:10 PM ET
Tango Therapeutics Just Improved On This 'Unprecedented' Cancer Drug
Investor's Business Daily · Oct 23, 2026 4:06 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RVMD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.